title: Decreasing prematurity in twin gestations: predicaments and possibilities.
abstract: The twin birth rate has been steadily increasing in the United States over the past 10 years attributable in large part to the increased use of reproductive technologies. Despite advancements in the prevention of preterm labor for singletons, the overall rate of preterm birth has decreased only minimally. Several interventions to prevent preterm birth in twins have been studied, but none has proven effective. Inpatient bedrest has not been shown to be effective and can cause significant maternal morbidity. Although intramuscular 17α-hydroxyprogesterone caproate is effective in decreasing the risk of recurrent preterm delivery in singletons, neither it nor cerclage is effective in twin gestations, even in those with a short cervix. However, small trials, subgroup analyses, and a meta-analysis suggest that vaginal progesterone and the Arabin cervical pessary may reduce rates of preterm birth in twins of mothers with a short cervix. Given the current lack of effective therapies to prevent preterm birth in twins, large multicenter trials are needed to assess the effectiveness of vaginal progesterone and pessary in twins of mothers with a short cervix.
authors: Department of Obstetrics and Gynecology, division of Maternal-Fetal Medicine, Columbia University, New York, New York; the University of Alabama at Birmingham, Birmingham, Alabama; and Brown University, Providence, Rhode Island.
authors: Noelia
authors: N
authors: Zork
authors: Joseph
authors: J
authors: Biggio
authors: Alan
authors: A
authors: Tita
authors: Dwight
authors: D
authors: Rouse
authors: Cynthia
authors: C
authors: Gyamfi-Bannerman
mesh_terms: D005260:Female; D006801:Humans; D011247:Pregnancy; D059285:Pregnancy, Twin; D047928:Premature Birth / Q000209:etiology* / Q000517:prevention & control; D014427:Twins
references: Martin JA, Hamilton BE, Osterman MJ. Three decades of twin births in the United States, 1980–2009. NCHS Data Brief 2012:1–8.
references: Martin JA, Hamilton BE, Ventura SJ, Osterman MJK, Wilson EC, Mathews TJ. Births: final data for 2010. Natl Vital Stat Rep 2012;61:1–72.
references: Blondel B, Kaminski M. Trends in the occurrence, determinants, and consequences of multiple births. Semin Perinatol 2002;26:239–49.
references: Luke B, Brown MB. The changing risk of infant mortality by gestation, plurality, and race: 1989–1991 versus 1999–2001. Pediatrics 2006;118:2488–97.
references: Rouse DJ, Caritis SN, Peaceman AM, Sciscione A, Thom EA, Spong CY, et al.. A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins. N Engl J Med 2007;357:454–61.
references: Goldenberg RL, Iams JD, Miodovnik M, Van Dorsten JP, Thurnau G, Bottoms S, et al.. The preterm prediction study: risk factors in twin gestations. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Am J Obstet Gynecol 1996;175:1047–53.
references: Ou CW, Chen ZQ, Qi S, Lye SJ. Increased expression of the rat myometrial oxytocin receptor messenger ribonucleic acid during labor requires both mechanical and hormonal signals. Biol Reprod 1998;59:1055–61.
references: Sooranna SR, Engineer N, Loudon JA, Terzidou V, Bennett PR, Johnson MR. The mitogen-activated protein kinase dependent expression of prostaglandin H synthase-2 and interleukin-8 messenger ribonucleic acid by myometrial cells: the differential effect of stretch and interleukin-1{beta}. J Clin Endocrinol Metab 2005;90:3517–27.
references: Kanayama N, Fukamizu H. Mechanical stretching increases prostaglandin E2 in cultured human amnion cells. Gynecol Obstet Invest 1989;28:123–6.
references: Mahendroo M. Cervical remodeling in term and preterm birth: insights from an animal model. Reproduction 2012;143:429–38.
references: Kallen B, Finnstrom O, Lindam A, Nilsson E, Nygren KG, Olausson PO. Selected neonatal outcomes in dizygotic twins after IVF versus non-IVF pregnancies. BJOG 2010;117:676–82.
references: Cheang CU, Huang LS, Lee TH, Liu CH, Shih YT, Lee MS. A comparison of the outcomes between twin and reduced twin pregnancies produced through assisted reproduction. Fertil Steril 2007;88:47–52.
references: Hediger ML, Luke B, Gonzalez-Quintero VH, Martin D, Nugent C, Witter FR, et al.. Fetal growth rates and the very preterm delivery of twins. Am J Obstet Gynecol 2005;193:1498–507.
references: Dubois S, Dougherty C, Duquette MP, Hanley JA, Moutquin JM. Twin pregnancy: the impact of the Higgins Nutrition Intervention Program on maternal and neonatal outcomes. Am J Clin Nutr 1991;53:1397–403.
references: Luke B, Brown MB, Misiunas R, Anderson E, Nugent C, van de Ven C, et al.. Specialized prenatal care and maternal and infant outcomes in twin pregnancy. Am J Obstet Gynecol 2003;189:934–8.
references: Nageotte MP. Prevention and treatment of preterm labor in twin gestation. Clin Obstet Gynecol 1990;33:61–8.
references: Crowther CA, Neilson JP, Verkuyl DA, Bannerman C, Ashurst HM. Preterm labour in twin pregnancies: can it be prevented by hospital admission? Br J Obstet Gynaecol 1989;96:850–3.
references: MacLennan AH, Green RC, O'Shea R, Brookes C, Morris D. Routine hospital admission in twin pregnancy between 26 and 30 weeks’ gestation. Lancet 1990;335:267–9.
references: Haas DM, Caldwell DM, Kirkpatrick P, McIntosh JJ, Welton NJ. Tocolytic therapy for preterm delivery: systematic review and network meta-analysis. BMJ 2012;345:e6226.
references: Avrech OM, Golan A, Weinraub Z, Bukovsky I, Caspi E. Mifepristone (RU486) alone or in combination with a prostaglandin analogue for termination of early pregnancy: a review. Fertil Steril 1991;56:385–93.
references: Challis JRG, Matthews SG, Gibb W, Lye SJ. Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev 2000;21:514–50.
references: Briery CM, Veillon EW, Klauser CK, Martin RW, Chauhan SP, Magann EF, et al.. Progesterone does not prevent preterm births in women with twins. South Med J 2009;102:900–4.
references: Durnwald CP, Momirova V, Rouse DJ, Caritis SN, Peaceman AM, Sciscione A, et al.. Second trimester cervical length and risk of preterm birth in women with twin gestations treated with 17-alpha hydroxyprogesterone caproate. J Matern Fetal Neonatal Med 2010;23:1360–4.
references: Combs CA, Garite T, Maurel K, Das A, Porto M; Obstetrix Collaborative Research N. 17-hydroxyprogesterone caproate for twin pregnancy: a double-blind, randomized clinical trial. Am J Obstet Gynecol 2011;204:221.e1–8.
references: Cetingoz E, Cam C, Sakalli M, Karateke A, Celik C, Sancak A. Progesterone effects on preterm birth in high-risk pregnancies: a randomized placebo-controlled trial. Arch Gynecol Obstet 2011;283:423–9.
references: Norman JE, Mackenzie F, Owen P, Mactier H, Hanretty K, Cooper S, et al.. Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis. Lancet 2009;373:2034–40.
references: Rode L, Klein K, Nicolaides KH, Krampl-Bettelheim E, Tabor A; PREDICT Group. Prevention of preterm delivery in twin gestations (PREDICT): a multicenter, randomized, placebo-controlled trial on the effect of vaginal micronized progesterone. Ultrasound Obstet Gynecol 2011;38:272–80.
references: Klein K, Rode L, Nicolaides KH, Krampl-Bettelheim E, Tabor A; PREDICT Group. Vaginal micronized progesterone and risk of preterm delivery in high-risk twin pregnancies: secondary analysis of a placebo-controlled randomized trial and meta-analysis. Ultrasound Obstet Gynecol 2011;38:281–7.
references: Fonseca EB, Celik E, Parra M, Singh M, Nicolaides KH; Fetal Medicine Foundation Second Trimester Screening Group. Progesterone and the risk of preterm birth among women with a short cervix. N Engl J Med 2007;357:462–9.
references: Dor J, Shalev J, Mashiach S, Blankstein J, Serr DM. Elective cervical suture of twin pregnancies diagnosed ultrasonically in the first trimester following induced ovulation. Gynecol Obstet Invest 1982;13:55–60.
references: Berghella V, Odibo AO, To MS, Rust OA, Althuisius SM. Cerclage for short cervix on ultrasonography: meta-analysis of trials using individual patient-level data. Obstet Gynecol 2005;106:181–9.
references: Cross RG. Treatment of habitual abortion due to cervical incompetence. Lancet 1959;2:127.
references: Newcomer J. Pessaries for the treatment of incompetent cervix and premature delivery. Obstet Gynecol Surv 2000;55:443–8.
references: Arabin B, Halbesma JR, Vork F, Hubener M, van Eyck J. Is treatment with vaginal pessaries an option in patients with a sonographically detected short cervix? J Perinat Med 2003;31:122–33.
references: Goya M, Pratcorona L, Merced C, Rodo C, Valle L, Romero A, et al.. Cervical pessary in pregnant women with a short cervix (PECEP): an open-label randomised controlled trial. Lancet 2012;379:1800–6.
references: Acharya G, Eschler B, Gronberg M, Hentemann M, Ottersen T, Maltau JM. Noninvasive cerclage for the management of cervical incompetence: a prospective study. Arch Gynecol Obstet 2006;273:283–7.
references: Liem S, Schuit E, Bais J, de Boer K, Bloemenkamp K, Brons J, et al.. Pessaries in multiple pregnancy as a prevention of preterm birth (ProTWIN): a randomized controlled trial. Am J Obstet Gynecol 2013;208(suppl 1):S2.
references: Dharan VB, Ludmir J. Alternative treatment for a short cervix: the cervical pessary. Semin Perinatol 2009;33:338–42.
references: Combs CA. Vaginal progesterone or cerclage to prevent recurrent preterm birth? Am J Obstet Gynecol 2013;208:1–2.